Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METHOTREXATE FOR INJECTION safely and effectively. See full prescribing information for METHOTREXATE FOR INJECTION. METHOTREXATE for Injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953
Medication labelWhy this: Advisory · dailymed-prescription
Methotrexate for Injection is indicated for the treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy regimen. Methotrexate for Injection is indicated for the prophylaxis and treatment of meningeal leukemia in adult and pediatric patients. Methotrexate for Injection is indicated for the treatment of adults and pediatric patients with Non-Hodgkin lymphoma. Methotrexate for Injection is indicated for the treatment of adults and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen. Methotrexate for Injection is indicated for the treatment of adults with breast cancer as part of a combination chemotherapy regimen. Methotrexate for Injection is indicated for the treatment of adults with squamous cell carcinoma of the head and neck as a single-agent. Methotrexate for Injection is indicated for the treatment of adults with gestational trophoblastic neoplasia (GTN) as part of a combination chemotherapy regimen. Methotrexate for Injection is indicated for the treatment of adults with rheumatoid arthritis (RA). Methotrexate for Injection is indicated for the treatment of pediatric patients with polyarticular Juvenile Idiopathic Arthritis (pJIA). Methotrexate for Injection is indicated for the treatment of adults with severe psoriasis.
- generic_name
- methotrexate sodium
- product_names
- METHOTREXATE SODIUM
- ndc
- 63323-122, 63323-122-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en